Skip to main content
. 2019 Mar 28;57(1):145–153. doi: 10.1080/13880209.2019.1585460

Table 3.

Inflammatory cytokine panel and liver function of subjects at baseline to 22 h.

  Baseline
Hour 2
Hour 12
Hour 22
  treatment Placebo treatment Placebo treatment Placebo treatment Placebo
CRP 0.89 ± 0.97 0.72 ± 0.88 0.90 ± 0.92 0.72 ± 0.82 0.83 ± 0.72 0.68 ± 0.79 0.86 ± 0.87 0.73 ± 0.85
Inflammatory cytokine panel                
 TNF-α 4.74 ± 1.10 5.07 ± 1.39 4.74 ± 1.03 5.00 ± 1.25 4.25 ± 1.14 4.52 ± 0.74 5.16 ± 1.68 5.30 ± 1.16
 IL-1β 8.27 ± 3.73 7.81 ± 1.88 7.32 ± 1.79 7.82 ± 1.84 7.48 ± 1.79 7.60 ± 2.09 8.47 ± 1.92 8.40 ± 2.73
 IL-2 4.17 ± 0.65 4.48 ± 0.83 4.15 ± 0.51 4.23 ± 0.84 4.01 ± 0.65 3.96 ± 0.64 4.43 ± 0.91 4.71 ± 1.14
 IL-4 5.39 ± 1.60 5.09 ± 1.10 5.08 ± 1.56 5.27 ± 1.44 4.76 ± 1.57 4.79 + 0.63 5.92 ± 2.26 5.21 ± 1.07
 IL-5 4.36 ± 1.55 4.16 ± 0.98 405 ± 1.07 4.67 ± 1.05 3.90 ± 1.00 4.45 ± 1.79 4.15 ± 0.94 4.70 ± 1.75
 IL-6 2.94 ± 0.26 3.02 ± 0.05 3.02 ± 0.05 3.02 ± 0.05 3.00 ± 0.38 2.97 ± 0.13 3.27 ± 0.46 3.06 ± 0.14
 IL-8 4.83 ± 0.79 5.24 ± 1.07 4.68 ± 0.73 4.77 ± 0.78 8.72 ± 4.84 5.69 ± 1.40 5.28 ± 0.68 4.19 ± 0.81#
 IL-10 3.82 ± 0.61 4.35 ± 0.76 4.15 ± 0.62 4.04 ± 0.56 3.92 ± 0.40 4.10 ± 0.71 4.09 ± 0.45 4.23 ± 0.71#
 IL-12p70 3.98 ± 0.80 4.99 ± 1.49 4.30 ± 0.70 4.48 ± 0.65 4.02 ± 0.54 4.41 ± 0.96 4.54 ± 0.84 4.62 ± 0.64#
 IL-13 4.88 ± 0.94 4.84 ± 0.88 4.90 ± 0.96 5.21 ± 1.03 4.70 ± 0.74 4.61 ± 0.82 4.84 ± 0.84 5.11 ± 0.99
 IL-17A 3.61 ± 0.47 3.87 ± 0.74 3.63 ± 0.48 3.73 ± 0.46 4.00 ± 0.53 3.68 ± 0.45 3.53 ± 0.52 3.67 ± 0.49
 GM-CSF factor 5.87 ± 0.99 5.84 ± 0.53 5.55 ± 0.48 6.24 ± 0.78 5.51 ± 0.63 5.85 ± 0.80 6.27 ± 1.16 6.23 ± 1.01
 Eotaxin 54.10 ± 39.89 68.67 ± 44.12 61.07 ± 50.93 55.02 ± 30.01 90.33 ± 61.2 92.93 ± 62.66 98.57 ± 67.84 87 ± 61.56
 MIP-1beta 422.67 ± 161.14 410.72 ± 171.99 411.07 ± 195.48 381.52 ± 176.67 556.52 ± 183.08 586.23 ± 222.62 462.71 ± 145.04 485.18 ± 197.25
 IFN-γ 5.67 ± 1.77 6.40 ± 2.10 5.66 ± 1.63 5.49 ± 1.26 5.54 ± 2.04 6.03 ± 2.62 5.78 ± 1.91 6.18 ± 2.32
 VEGF 47.86 ± 24.02 61.67 ± 40.74 45.65 ± 24.23 51.33 ± 30.81 57.64 ± 37.68 64.72 ± 44.88 54.89 ± 29.34 62.12 ± 37.67
 MCP-1 16.43 ± 6.31 15.54 ± 4.66 14.35 ± 5.09 15.15 ± 4.66 18.28 ± 5.21 20.64 ± 8.28 16.8 ± 4.67 17.55 ± 5.80
 FGF-basic 4.31 ± 0.46 4.46 ± 0.51 4.30 ± 0.59 4.50 ± 0.56 4.55 ± 0.89 4.32 ± 0.46 4.70 ± 0.45 4.51 ± 0.50
Liver function tests                
 AST 21.8 ± 8.61 18.13 ± 5.30 21.6 ± 8.26 18.87 ± 5.14 18.79 ± 6.58 17.07 ± 3.9 17.08 ± 4.91 17.27 ± 3.84
 ALT 18.13 ± 8.79 16 ± 5.68 18.33 ± 8.74 16.13 ± 5.65 16.21 ± 8.38 15.4 ± 5.15 15.92 ± 8.25 15.53 ± 5.64
 Total bilirubin 0.51 ± 0.2 0.49 ± 0.22 0.48 ± 0.15 0.47 ± 0.17 0.42 ± 0.15 0.39 ± 0.12 0.59 ± 0.21 0.54 ± 0.22
 Albumin 4.53 ± 0.29 4.41 ± 0.32 4.59 ± 0.35 4.45 ± 0.34 4.36 ± 0.35 4.36 ± 0.43 4.41 ± 0.31 4.45 ± 0.41
 INR 1.04 ± 0.07 1.03 ± 006 1.03 ± 0.07 1.04 ± 0.06 1.06 ± 0.11 1.07 ± 0.09 1.06 ± 0.08 62.47 ± 14.88
 ALK 63.88 ± 13.08 67.44 ± 14.17 66.31 ± 14.62 69.84 ± 13.31 62.84 ± 14.76 67.41 ± 15.23 62.47 ± 14.88 67.88 ± 15.61
 GSH-Px 69.89 ± 15.77 74.69 ± 16.18 70.46 ± 15.52 71.48 ± 14.27 70.79 ± 9.60 75.3 ± 13.26 73.79 ± 11.66 76.86 ± 12.88

# p < 0.05, Denotes significant difference of active compared to placebo.